Program
Lubricant Eye Drops
Also written as “Artificial Tear”, “Lubricant Eye Drops (Optive™)” and “Lubricating Eye Drops (blink® Tears)”.
Its studies are mostly in Keratoconjunctivitis Sicca · Dry Eye Syndromes · Inflammation, led by 2 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| AbbVie | 20 open or running | phase 4since Sep 18, 2008 | Sep 18, 2008 | none ahead |
| BRIM Biotechnology | 11 open or running | phase 2since Jul 14, 2025 | Jul 14, 2025 | Nov 2026phase 2 · NCT07078955 |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 18, 2008First study: phase 4 study in Dry Eye SyndromesNew to AbbVieAbbVie · NCT00756678 · 51 enrolled · United States
- Nov 12, 2008Phase 4 study in InflammationAbbVie · NCT00791323 · 9 enrolled · United States
- Jul 14, 2025BRIM Biotechnology's first study: phase 2 study in Dry Eye SyndromesNew to BRIM BiotechnologyBRIM Biotechnology · NCT07078955 · 99 planned · Taiwan
Ahead
- Nov 2026Primary completion: phase 2 study in Dry Eye SyndromesBRIM Biotechnology · NCT07078955
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07078955Dry Eye Syndromes · Taiwan | 2 | Not yet recruiting | BRIM Biotechnology | Nov 2026 | 99 |
| NCT00791323Inflammation · United States | 4 | Completed | AbbVie | Aug 2009 | 9 |
| NCT00756678Dry Eye Syndromes · United States | 4 | Completed | AbbVie | Aug 2009 | 51 |
How it is read
Names in the registry
- “Artificial Tear”, 1 entry
- “Lubricant Eye Drops (Optive™)”, 1 entry
- “Lubricating Eye Drops (blink® Tears)”, 1 entry
- “Lubricating Eye Drop”, 1 entry
Conditions, from the studies’ own filings
- Keratoconjunctivitis Sicca, 1 study
- Dry Eye Syndromes, 1 study
- Inflammation, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.